Remedent, Inc. Receives Initial Purchase Order From CVS Pharmacy Stores
February 13 2008 - 12:38PM
Business Wire
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, manufacturing of oral care and
cosmetic dentistry products, announced today that it has received a
significant initial purchase order for its iWhite teeth whitening
system from CVS Caremark Corporation. Under the terms of the order,
Remedent will initially ship this quarter two SKUs per store, one
the iWhite Light Activated Teeth Whitening Kit and the other the
iWhite Maintenance Stick. In addition to shipping these products to
more than 6,200 CVS drug stores for availability on the store
shelves in April 2008, Remedent will also deliver each SKU to
various CVS warehouses across the U.S. �We are very pleased to
announce this initial purchase order for our proprietary whitening
solution, iWhite, with CVS retail stores,� stated Mr. Robin List,
Chief Executive Officer of Remedent. �This purchase order is a
major breakthrough for Remedent in building the Company�s presence
in the U.S. market. CVS is one of the largest drug store chains in
the U.S. and a market leader within the retail industry. To support
this initiative, we plan on commencing a cooperative advertising
and media campaign with CVS and are hopeful to advancing iWhite
into other retail channels in the future.� About Remedent, Inc.
Remedent, Inc., a publicly-traded company on the OTCBB, specializes
in the research, development, manufacturing and marketing of oral
care and cosmetic dentistry products. With offices in California,
Belgium and Singapore, Remedent distributes its products in more
then 35 countries. For additional information, visit Remedent's web
site at www.remedent.com. About CVS Caremark Corporation CVS
Caremark is the nation's premier integrated pharmacy services
provider, combining one of the nation's leading pharmaceutical
services companies with the country�s largest pharmacy chain. The
company fills or manages more than one billion prescriptions per
year, more than any other pharmacy services provider. CVS Caremark
drives value for pharmacy services customers by effectively
managing pharmaceutical costs and improving healthcare outcomes
through its 6,200 CVS/pharmacy stores; its pharmacy benefit
management, mail order and specialty pharmacy division, Caremark
Pharmacy Services; its retail-based health clinic subsidiary,
MinuteClinic; and its online pharmacy, CVS.com. FORWARD-LOOKING
STATEMENTS �Safe Harbor� Statement under the Private Securities
Litigation Reform Act of 1995: The statements by Robin List,
optimism related to the business, expanding sales, the US and
international markets�and other statements in this press release
are forward-looking statements within the meaning of the Securities
Litigation Reform Act of 1995. Such statements are based on current
expectations, estimates and projections about the Company�s
business. Words such as expects, anticipates, intends, plans,
believes, sees, estimates and variations of such words and similar
expressions are intended to identify such forward-looking
statements. These statements are not guarantees of future
performance and involve certain risks and uncertainties that are
difficult to predict. Actual results could vary materially from the
description contained herein due to many factors including
continued market acceptance of the Company�s products. In addition,
actual results could vary materially based on changes or slower
growth in the oral care and cosmetic dentistry products market; the
potential inability to realize expected benefits and synergies;
domestic and international business and economic conditions;
changes in the dental industry; unexpected difficulties in
penetrating the oral care and cosmetic dentistry products market;
changes in customer demand or ordering patterns; changes in the
competitive environment including pricing pressures or
technological changes; technological advances; shortages of
manufacturing capacity; future production variables impacting
excess inventory and other risk factors listed from time to time in
the Company�s Securities and Exchange Commission filings under
�risk factors� and elsewhere. The forward-looking statements
contained in this press release speak only as of the date on which
they are made, and the Company does not undertake any obligation to
update any forward-looking statement to reflect events or
circumstances after the date of this press release.
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024